Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06336538 · ClinicalTrials.gov registry record · NA

Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors

A NA study of Breast Cancer and Breast Cancer Female, sponsored by Case Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT06336538 is a NA study of Breast Cancer and Breast Cancer Female that is active but no longer recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 23 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06336538, a NA study of Breast Cancer and Breast Cancer Female, is active but no longer recruiting, sponsored by Case Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.

Interventions

  • OTHER MBCT

Study Locations (1)

Ohio

  • Cleveland Clinic Department of Wellness and Preventive Medicine - Cleveland

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2025-03-21
Est. Completion 2026-09
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT06336538

The ClinicalTrials.gov registry entry for NCT06336538 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MBCT is the first listed.

NCT06336538 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06336538 about?

NCT06336538 is a clinical study titled "Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors". The purpose of this research study is to develop and test an intervention designed to improve mood and reduce symptoms of depression.

What is the current status of trial NCT06336538?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2025-03-21. Estimated completion is 2026-09.

What conditions does trial NCT06336538 study?

This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female, Breast Cancer Stage II, Breast Cancer Stage III, Breast Cancer Stage I.

What interventions are being tested in trial NCT06336538?

The interventions under investigation include: MBCT (OTHER).

Who is sponsoring clinical trial NCT06336538?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06336538 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.